공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 임상시험 의약품 포장 시장(2020-2024년)

Clinical Trial Packaging Market by End-user and Geography - Forecast and Analysis 2020-2024

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2019년 12월 상품 코드 922439
페이지 정보 영문 146 Pages
가격
US $ 2,500 ₩ 2,776,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,331,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,442,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,553,000 PDF (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 임상시험 의약품 포장 시장(2020-2024년) Clinical Trial Packaging Market by End-user and Geography - Forecast and Analysis 2020-2024
발행일 : 2019년 12월 페이지 정보 : 영문 146 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 임상시험 의약품 포장 시장은 2020-2024년간 4% 이상의 연평균 복합 성장률(CAGR)로 성장하고, 6억 6,692만 달러 규모에 달할 전망입니다. 신약 승인 증가가 시장 성장요인이 되고 있습니다. 또한 임상 연구에서의 AI 출현이 세계 임상시험 의약품 포장 시장의 성장을 뒷받침 할 것으로 예상되고 있습니다.

세계의 임상시험 의약품 포장(Clinical Trial Packaging) 시장에 대해 조사 분석하고, 시장 규모 및 성장률, 시장 동향, 시장 성장 촉진요인과 과제, 시장 기회 분석, 주요 벤더 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 개요

제2장 조사 범위

  • 서론 1
  • 서론 2
  • 달러의 통화 환산율

제3장 시장 상황

  • 시장 생태계
  • 시장의 특징
  • 시장 세분화 분석
  • 밸류체인 분석

제4장 시장 규모

  • 시장 정의
  • 시장 규모(2019년)
  • 시장 규모 및 예측(2019-2024년)
  • 시장 전망

제5장 Five Forces 분석

  • 구매자의 교섭력
  • 공급업체의 협상력
  • 신규 진출기업의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시황

제6장 시장 세분화 : 최종사용자별

  • 시장 세분화 : 최종사용자별
  • 최종사용자별 비교 : 시장 규모 및 예측(2019-2024년)
  • 제약회사
  • 기타 조직
  • 시장 기회 : 최종사용자별

제7장 고객 상황

제8장 지역 상황

  • 지역별 세분화
  • 지역별 비교 : 시장 규모 및 예측(2019-2024년)
  • 북미
  • 유럽
  • 아시아
  • 기타 지역
  • 주요 국가
  • 시장 기회

제9장 의사결정 프레임워크

제10장 성장요인과 과제

  • 시장 성장 촉진요인
  • 시장의 과제

제11장 시장 동향

  • 임상 연구에서 AI의 출현
  • CRO로의 아웃소싱 활동 증가
  • 의약품 생산에서의 클라우드 기술 채택 및 검사 증가

제12장 벤더 상황

  • 개요
  • 파괴적 혁신
  • 경쟁 시나리오

제13장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Bilcare Ltd.
  • Caligor Coghlan Pharma Services
  • Corden Pharma International GmbH
  • Mawdsley-Brooks & Co. Ltd.
  • PCI Pharma Services
  • Piramal Enterprises Ltd.
  • Sentry BioPharma Services
  • Sharp
  • The WestRock group
  • Thermo Fisher Scientific Inc.

제14장 부록

  • 조사 방법
  • 약어 리스트
  • 벤더의 시장 포지셔닝 정의

제15장 TECHNAVIO에 대해

LSH 20.01.28

LIST OF EXHIBITS:

  • Exhibit 01: Vendors: Key offerings
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: End-user - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Pharmaceutical companies - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Pharmaceutical companies - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Other organizations - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Other organizations - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by end-user
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Top 3 countries in North America
  • Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 33: Top 3 countries in Europe
  • Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Top 3 countries in Asia
  • Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 38: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 39: Top 3 countries in ROW
  • Exhibit 40: Key leading countries
  • Exhibit 41: Market opportunity
  • Exhibit 42: Impact of drivers and challenges
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: Bilcare Ltd. - Vendor overview
  • Exhibit 49: Bilcare Ltd. - Business segments
  • Exhibit 50: Bilcare Ltd. - Key offerings
  • Exhibit 51: Bilcare Ltd. - Key customers
  • Exhibit 52: Caligor Coghlan Pharma Services - Vendor overview
  • Exhibit 53: Caligor Coghlan Pharma Services - Business segments
  • Exhibit 54: Caligor Coghlan Pharma Services - Organizational developments
  • Exhibit 55: Caligor Coghlan Pharma Services - Key offerings
  • Exhibit 56: Caligor Coghlan Pharma Services - Key customers
  • Exhibit 57: Corden Pharma International GmbH - Vendor overview
  • Exhibit 58: Corden Pharma International GmbH - Business segments
  • Exhibit 59: Corden Pharma International GmbH - Organizational developments
  • Exhibit 60: Corden Pharma International GmbH - Key offerings
  • Exhibit 61: Corden Pharma International GmbH - Key customers
  • Exhibit 62: Mawdsley-Brooks & Co. Ltd. - Vendor overview
  • Exhibit 63: Mawdsley-Brooks & Co. Ltd. - Business segments
  • Exhibit 64: Mawdsley-Brooks & Co. Ltd. - Organizational developments
  • Exhibit 65: Mawdsley-Brooks & Co. Ltd. - Key offerings
  • Exhibit 66: Mawdsley-Brooks & Co. Ltd. - Key customers
  • Exhibit 67: PCI Pharma Services - Vendor overview
  • Exhibit 68: PCI Pharma Services - Business segments
  • Exhibit 69: PCI Pharma Services - Organizational developments
  • Exhibit 70: PCI Pharma Services - Key offerings
  • Exhibit 71: PCI Pharma Services - Key customers
  • Exhibit 72: Piramal Enterprises Ltd. - Vendor overview
  • Exhibit 73: Piramal Enterprises Ltd. - Business segments
  • Exhibit 74: Piramal Enterprises Ltd. - Organizational developments
  • Exhibit 75: Piramal Enterprises Ltd. - Segment focus
  • Exhibit 76: Piramal Enterprises Ltd. - Key offerings
  • Exhibit 77: Piramal Enterprises Ltd. - Key customers
  • Exhibit 78: Sentry BioPharma Services - Vendor overview
  • Exhibit 79: Sentry BioPharma Services - Business segments
  • Exhibit 80: Sentry BioPharma Services - Key offerings
  • Exhibit 81: Sentry BioPharma Services - Key customers
  • Exhibit 82: Sharp - Vendor overview
  • Exhibit 83: Sharp - Business segments
  • Exhibit 84: Sharp - Organizational developments
  • Exhibit 85: Sharp - Geographic focus
  • Exhibit 86: Sharp - Key offerings
  • Exhibit 87: Sharp - Key customers
  • Exhibit 88: The WestRock group - Vendor overview
  • Exhibit 89: The WestRock group - Business segments
  • Exhibit 90: The WestRock group - Organizational developments
  • Exhibit 91: The WestRock group - Segment focus
  • Exhibit 92: The WestRock group - Key offerings
  • Exhibit 93: The WestRock group - Key customers
  • Exhibit 94: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 95: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 96: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 97: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 98: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 99: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 100: Thermo Fisher Scientific Inc. - Key customers
  • Exhibit 101: Validation techniques employed for market sizing
  • Exhibit 102: Definition of market positioning of vendors

Technavio has been monitoring the global clinical trial packaging market, and it is poised to grow by USD667.92 million during 2020-2024, progressing at a CAGR of over 4% during the forecast period. Our reports on global clinical trial packaging market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing approval of novel drugs. Also, the advent of AI in clinical research is anticipated to boost the growth of the global clinical trial packaging market as well.

Market Segmentation

Technavio's global clinical trial packaging market is segmented as below:

End-users

  • Pharmaceutical companies
  • Organizations

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global clinical trial packaging market growth

This study identifies advent of AI in clinical research as the prime reason driving the global clinical trial packaging market growth during the next few years.

Prominent vendors in global clinical trial packaging market

We provide a detailed analysis of around 25 vendors operating in the global clinical trial packaging market, including some of the vendors such as Bilcare Ltd., Caligor Coghlan Pharma Services, Corden Pharma International GmbH, Mawdsley-Brooks & Co. Ltd., PCI Pharma Services, Piramal Enterprises Ltd., Sentry BioPharma Services, Sharp, The WestRock group and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical companies - Market size and forecast 2019-2024
  • Other organizations - Market size and forecast 2019-2024
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Advent of AI in clinical research
  • Increasing outsourcing activities to CROs
  • Increasing adoption of cloud technologies in pharmaceutical production
  • and testing

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bilcare Ltd.
  • Caligor Coghlan Pharma Services
  • Corden Pharma International GmbH
  • Mawdsley-Brooks & Co. Ltd.
  • PCI Pharma Services
  • Piramal Enterprises Ltd.
  • Sentry BioPharma Services
  • Sharp
  • The WestRock group
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Back to Top
전화 문의
F A Q